What is Next Ferm?
Next Ferm operates at the intersection of biotechnology and food science, specializing in the development of fermented vegan proteins. The company's core value proposition lies in its ability to enhance the nutritional profile and sensory characteristics of plant-based food products. Through its diverse portfolio, which includes ProteVin, Maximmune, AstaFerm, and NextFreeze, Next Ferm addresses the critical demand for high-quality, sustainable protein alternatives. By bridging the gap between industrial-scale production and consumer-grade nutrition, the company is effectively transforming the food industry's approach to plant-based innovation.
How much funding has Next Ferm raised?
Next Ferm has raised a total of $10.1M across 2 funding rounds:
Unspecified
$918K
Stock Offering
$9.2M
Unspecified (2021): $918K with participation from Ortal, Merage Foundations, Cider Holdings, Gadot Group, Arancia International, and Orgad Agricultural Cooperative
Stock Issuance/Offering (2021): $9.2M, investors not publicly disclosed
Key Investors in Next Ferm
Arancia International
Arancia International is a diversified group with a strong focus on biotechnology, value-added services, and institutional investments.
Merage Foundations
A philanthropic and investment organization dedicated to fostering innovation and economic development across various sectors.
Gadot Group
A global leader in the supply of ingredients and chemical solutions, specializing in the food, beverage, and pharmaceutical industries.
What's next for Next Ferm?
With the recent influx of capital, Next Ferm is poised to execute an aggressive growth strategy focused on market penetration and product diversification. The company is expected to prioritize the scaling of its fermentation infrastructure to meet the rising demand from global food manufacturers seeking to integrate superior protein solutions into their supply chains. Furthermore, the strategic nature of this investment suggests a focus on long-term R&D initiatives, potentially leading to the commercialization of new, high-performance protein derivatives. As the firm matures, its ability to maintain quality while scaling production will be the primary determinant of its continued success in the global food-tech ecosystem.
See full Next Ferm company page
